- This event has passed.
Ketamine for Depression and Suicide Prevention in VA
February 14 @ 2:00 pm - 3:30 pm
Ketamine for Depression and Suicide Prevention in VA
February 14 2024 2:00 ET Eric Hermes, MD
Visit https://www.mirecc.va.gov/visn19/cpg/webinar.asp for information and to register.
Treatment-resistant depression and suicidality are common and interrelated problems for Veterans. Ketamine is a dissociative anesthetic drug that has recently been investigated as a treatment option. Eric Hermes, MD, will review the history and role of ketamine in the treatment of depression and suicidality and discuss the implementation of ketamine delivery programs across VA. This webinar will improve participant’s understanding of the role of ketamine in VA mental health treatment.
Following this live webinar, particpants will be able to:
- Define treatment-resistant depression and its approximate prevalence among Veterans using VA services.
- Identify the role of ketamine in the treatment of Veterans with depression and suicidality in VA.
- Describe the deployment of ketamine and other somatic treatment programs across VA.
Eric Hermes, MD
Dr. Hermes is the Director for Psychopharmacology and Somatic Treatments in the VA Office of Mental Health and Suicide Prevention. He is a psychiatrist and associate professor in the Department of Psychiatry at the Yale University School of Medicine, where he studies implementation and quality improvement in mental health services.